DNP Therapeutics
Cambridge, US · Founded 2026 · Delaware corporation
Founders & leadership
RC
Randall Craig MazzarinoNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$470K disclosed across 1 round · 2026
▶$470KraisedMar 2026 · 7 investors · Other TechnologyRule 506(b)
▶$470KraisedMar 2026 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Randall Craig MazzarinoExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $470K
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware, 2026
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has DNP Therapeutics raised?
- DNP Therapeutics has disclosed $470K raised across 1 round.
- Where is DNP Therapeutics headquartered?
- DNP Therapeutics is headquartered in Cambridge, US.